Tag: $Gilead Sciences

Gilead Just Bought $30 Million More of 2 Biotech Stocks

Gilead GILD +0.57% Sciences recently spent about $30 million to increase its stakes in two biotech stocks.

Gilead Gets Positive European Opinion for Additional Indication for Trodelvy

Gilead Sciences has received a positive response from the European Medicines Agency’s Committee for Medicinal Products for Human Use on an additional indication for the use of its antibody-drug conjugate Trodelvy in certain types of pre-treated breast cancer.